JM: Back to an old recommendation LONGCurrently 7.5 % Div.Yield... From the Wykhoff view during the year a really huuuuuge cause developed with a target above 360.
Gap Close in Fingerprint. 16.7 SEK I see a trend shift in fingerprint with raising bottoms and tops. Today we broke a range formation under high volume, so i think there is a good risk reward buying Fingerprint Cards now.
I do have shares in Fingerprint Cards and trading is under own responsibility
This is just a thought not a buy or sell recommendation
Volvo Short-SETUP! WHAT A R-R-R!#High-potentialHey tradomaniacs,
great chance that we are facing now!
WHAT A CRAZY Risk-REWARD-Ratio! All I`m concerend about is the fact that VOLVO-Stock seems to love the October!
If we break out of this pattern - DAMN BUY!
As soon as we bounce off that double-resistance it`s more likely that we`ll see the market going down!
Type: Swingtrade
Stop-loss: 163,-
Sell: 158,-
Target1: 150,-
Target 2: 137,9
Let`s see what happens! :-)
Both scenarios are very nice chances!
Peace and good trades
Irasor
Trading2ez
WANNA SEE MORE? Don`t forget to follow me.
Any questions? Need more detailed signals or education? PM me. :-)
Potenial swing play im looking at BUFABOMXSTO:BUFAB Entry target around 102ish
Looking to split up my entries between
102-100ish.
Cover 40% at 105 if sucessful
Move Stop Loss, let it ride
Cover rest 108-109.5
Stop Loss bellow 99
Markets can be beautifully unpredictable.On the 10th of September H&M signalled a strong bottom. This was a good sign to open a long position.
Didn't work immediately giving a bit of doubt, but the patient ones got rewarded.
7 days later it jumped 20%
Entry: 121
Exit: 135
Return: 11.5%
FINGERPRINT STEAMROLLERWeekly squeeze..
Volume increasing..
Untested levels..
Get on the train booys
Auriant MiningLook for Buy setups in the 2.00-2.20 Area . Has big potential to at least hit the first target @16 level , even go a more than that to a second target around ~20 area .
Eolus VindLooking for a bounce on the trend line before making purchase the RS line trending down is also a worry
Lets discuss the latest clinical trial report Lund Sweden, July 31, 2018 –Active Biotech (NASDAQ OMX NORDIC: ACTI) today provided an update regarding the clinical development of laquinimod by Teva Pharmaceutical Industries Ltd. The Phase 2 LEGATO-HD trial evaluating the safety and efficacy of laquinimod as a treatment in Huntington’s disease (HD) did not meet its primary endpoint of change from baseline after 12 months of treatment, as measured by the Unified Huntington’s Disease Rating Scale – Total Motor Score (UHDRS-TMS). The study’s secondary endpoint, reduction of brain atrophy (measured by caudate volume) was met. The safety results were similar to the expected event profile in this patient population.
prevalence Huntington disease= 2-10 / 100.000
Discussion: To date there is no cure for this degenerative disease, as published to the press the clinical trial currently at phase 2 did not meet the endpoint of changing the baseline for motor Score, this explains the profound falling of the price at that time (from 7 to 3 SEK). Now an important thought on this price action is the following. They managed to reduce the brain atrophy (i.e. the a decrements in the neural cellsize, or soma), which is in fact a much more reliable proof of work measurement than coining scores for the patients ability to control his/her movements , and in simple words means that the patient won't cure from this disease but he will deteriorate more slowly. Which is.... Progress right? En plus, the side effects are as expected. So, just from the research point of view this is not bad new, quite the contrary. For the price itself I believe it has a very tempting digit.
Happy trading
Emerging patternThis stock had been consolidating after a drop during earning releases but their consensus is still over 360-380 swedish crowns. It's looking like now it has formed a bull flag and should soon trade over 340 if the pattern completes.
Husqvarna B, Buy at Breakout ? Huge BB width, Postive Divergence and MACD Crossover, Good short term edge,
Gomspace 3 month viewI expect we will see a further drop down to close the gap, which will be my buy zone.
This would also be the 78% retracement, lets see how i pans out.
Happy trading
Atlas Copco (Sweden) Upcoming Short OpprtunityEverything is explained on the chart, no further explanation needed
